Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

NINDS boosts research for biomarkers in Parkinson's disease.

[No authors listed]

Lancet Neurol. 2013 Mar;12(3):217. doi: 10.1016/S1474-4422(13)70029-2. No abstract available.

PMID:
23415560
2.

Prioritized research recommendations from the National Institute of Neurological Disorders and Stroke Parkinson's Disease 2014 conference.

Sieber BA, Landis S, Koroshetz W, Bateman R, Siderowf A, Galpern WR, Dunlop J, Finkbeiner S, Sutherland M, Wang H, Lee VM, Orr HT, Gwinn K, Ludwig K, Taylor A, Torborg C, Montine TJ; Parkinson's Disease 2014: Advancing Research, Improving Lives Conference Organizing Committee..

Ann Neurol. 2014 Oct;76(4):469-72. doi: 10.1002/ana.24261. No abstract available.

PMID:
25164235
3.

The changing face of Parkinson's disease-associated psychosis: a cross-sectional study based on the new NINDS-NIMH criteria.

Fénelon G, Soulas T, Zenasni F, Cleret de Langavant L.

Mov Disord. 2010 Apr 30;25(6):763-6. doi: 10.1002/mds.22839.

4.

A 'bird's eye' view on the current status and potential benefits of blood biomarkers for Parkinson's disease.

Mielke MM, Maetzler W.

Biomark Med. 2014;8(2):225-7. doi: 10.2217/bmm.13.139. No abstract available.

PMID:
24521018
5.

The Coalition Against Major Diseases: developing tools for an integrated drug development process for Alzheimer's and Parkinson's diseases.

Romero K, de Mars M, Frank D, Anthony M, Neville J, Kirby L, Smith K, Woosley RL.

Clin Pharmacol Ther. 2009 Oct;86(4):365-7. doi: 10.1038/clpt.2009.165.

PMID:
19763117
6.

Biomarkers in Parkinson's disease: an update.

Shtilbans A, Henchcliffe C.

Curr Opin Neurol. 2012 Aug;25(4):460-5. doi: 10.1097/WCO.0b013e3283550c0d. Review.

PMID:
22772875
7.

Launch of a US$5 million Parkinson’s Disease Biomarkers Program in the USA.

King G.

Bioanalysis. 2013 Mar;5(5):527. No abstract available.

PMID:
23544251
8.

Story Landis.

Landis S, Mullard A.

Nat Rev Drug Discov. 2014 Oct;13(10):718-9. doi: 10.1038/nrd4454. No abstract available.

PMID:
25270951
9.

[Cerebrospinal fluid biomarkers for the early diagnosis of Parkinson's disease].

da Costa AG, Gago MF, Garrett C.

Acta Med Port. 2011 Dec;24 Suppl 4:761-8. Review. Portuguese.

10.

NINDS common data element project: a long-awaited breakthrough in streamlining trials.

Stone K.

Ann Neurol. 2010 Jul;68(1):A11-3. doi: 10.1002/ana.22114. No abstract available.

PMID:
20583225
11.

α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study.

Mollenhauer B, Locascio JJ, Schulz-Schaeffer W, Sixel-Döring F, Trenkwalder C, Schlossmacher MG.

Lancet Neurol. 2011 Mar;10(3):230-40. doi: 10.1016/S1474-4422(11)70014-X. Erratum in: Lancet Neurol. 2011 Apr;10(4):297.

PMID:
21317042
12.

The National Institutes of Health StrokeNet: A User's Guide.

Broderick JP, Palesch YY, Janis LS; National Institutes of Health StrokeNet Investigators..

Stroke. 2016 Feb;47(2):301-3. doi: 10.1161/STROKEAHA.115.011743. No abstract available.

13.

Biomarkers in Parkinson's disease.

Dorsey ER, Holloway RG, Ravina BM.

Expert Rev Neurother. 2006 Jun;6(6):823-31. Review.

PMID:
16784406
14.

Early diagnosis in Parkinson's disease.

Przuntek H.

J Neural Transm Suppl. 1992;38:105-14. Review.

PMID:
1491243
15.

Funding: NINDS seeks to reshape brain research.

Arnold C.

Lancet. 2014 Feb 22;383(9918):684. No abstract available.

PMID:
24567973
16.

Standardizing the structure of stroke clinical and epidemiologic research data: the National Institute of Neurological Disorders and Stroke (NINDS) Stroke Common Data Element (CDE) project.

Saver JL, Warach S, Janis S, Odenkirchen J, Becker K, Benavente O, Broderick J, Dromerick AW, Duncan P, Elkind MS, Johnston K, Kidwell CS, Meschia JF, Schwamm L; National Institute of Neurological Disorders and Stroke (NINDS) Stroke Common Data Element Working Group..

Stroke. 2012 Apr;43(4):967-73. doi: 10.1161/STROKEAHA.111.634352.

17.

Surrogate endpoints in Parkinson's disease research.

Biglan KM, Holloway RG.

Curr Neurol Neurosci Rep. 2003 Jul;3(4):314-20. Review.

PMID:
12930701
18.

Biomarkers for Parkinson's disease.

Graeber MB.

Exp Neurol. 2009 Apr;216(2):249-53. doi: 10.1016/j.expneurol.2008.12.017. Review.

PMID:
19166835
19.

StrokeNet Takes Off: National Institute of Neurological Disorders and Stroke Organizational Update.

Mott M, Janis S, Koroshetz WJ.

Stroke. 2016 Mar;47(3):e51-2. doi: 10.1161/STROKEAHA.115.012063. No abstract available.

20.

Combined therapies: National Institute of Neurological Disorders and Stroke funding opportunity in traumatic brain injury research.

Liu CY.

Neurosurgery. 2008 Oct;63(4):N12. doi: 10.1227/01.NEU.0000339457.01711.3B. No abstract available.

PMID:
18981867

Supplemental Content

Support Center